AstraZeneca: Following admissions by British pharmaceutical firm AstraZeneca in court regarding the unusual adverse effects of their vaccine, Serum Institute of India (SII) is facing legal action from the parents of a lady who purportedly died after taking Covishield. Produced by the Serum Institute of India, Covishield was created by AstraZeneca and Oxford University and was widely used in India.
Karunya’s Tragic Passing
Karunya, the daughter of Venugopalan Govindan, passed away in July 2021 following her Covishield vaccination. Nonetheless, the government-appointed national committee found insufficient evidence to draw the conclusion that the vaccine was the cause of her death.
In addition to asking for restitution, Govindan has filed a writ petition to appoint an impartial medical board to look into his daughter’s death. This is the result of AstraZeneca’s admission in court documents that a rare adverse effect of their vaccination could be reduced platelet count and blood clotting. AstraZeneca is being sued in a class-action case in the UK.
Global Distribution of Oxford-AstraZeneca Vaccine
Global distribution of the Oxford-AstraZeneca Covid vaccination was conducted under various trade names, including “Covishield” and “Vaxzevria.” In 2021, Rithaika Sri Omtri, then eighteen, had just finished her studies in architecture after graduating from Class 12. She started using Covishield in May.
But Rithaika couldn’t move, had a high fever, and began vomiting after only seven days. Her brain revealed several blood clots and a hemorrhage, according to an MRI scan. Two weeks later Rithaika was dead.
Rithaika’s Tragic Death Revealed
The precise reason for Rithaika’s death was unknown to her parents at the time. Rithaika’s death from “vaccine product related reaction” and “thrombosis with thrombocytopenia syndrome” were revealed to her family through an RTI in December 2021.
Jamie Scott filed the claim in the UK after getting the AstraZeneca vaccine in April 2021 and suffering a lifelong brain impairment. Because of safety concerns, the AstraZeneca-Oxford vaccination is no longer administered in the United Kingdom. Although independent research has demonstrated its efficacy in battling COVID-19, the appearance of uncommon side effects has sparked legal action and regulatory attention.
